• Sorry! To unlock all site features, we'll need to collect some information from you.

  • Unit 7.1: Aspirin and Thienopyridines

    Steven Steinhubl, MD — University of Kentucky

    Duration:1 hour

    Faculty Disclosure

    Consultant: Sanofi-Aventis; The Medicines Company; Astra Zeneca

    Learning Objectives

    • Review the mechanism of action of oral antiplatelet agents
    • Discuss short- and long-term outcomes in a wide range of clinical scenarios
    • Explore dosage and resistance issues
    • Provide a review of ongoing trials of antiplatelet agents and how they will substantially expand our understanding and improve patient care